Directors

Robert MacLeod, Director, bought 12 shares in the company on the 21st July 2021 at a price of £30.54. The Director now holds 70,097 shares....

John Laycock, Non Executive Director, received via a placing 200,000 shares in the company on the 22nd July 2021 at a price of £0.06. The...

John Allardyce, Executive Director, bought 3,600,000 shares in the company on the 24th March 2021 at a price of £0.00. The Director now holds 6,000,000...

John Allardyce, Executive Director, bought 2,400,000 shares in the company on the 24th March 2021 at a price of £0.00. The Director now holds 2,400,000...

John Allardyce, Executive Director, sold 6,000,000 shares in the company on the 24th March 2021 at a price of £0.00.

Director deals data provided by...

AstraZeneca has appointed Andreas Rummelt as a non-executive director, following the completion of its acquisition of Alexion Pharmaceuticals, Inc.

Dr. Rummelt has been a member...

Isabelle Maddock, Executive Director, has transferred in 176 shares in the company on the 20th July 2021 at a price of £0.00. The Director now...

Martin Thompson, Executive Director, has transferred in 176 shares in the company on the 20th July 2021 at a price of £0.00. The Director now...

Philip Wild, Chief Executive Officer, has transferred in 176 shares in the company on the 20th July 2021 at a price of £0.00. The Director...

Christopher Rogers, Non Executive Director, bought 35,000 shares in the company on the 20th July 2021 at a price of £1.67. The Director now holds...